Skip to main content
Log in

Effects of dofetilide on electrical dispersion and arrhythmias in post-infarcted anesthetized dogs

  • Original Contribution
  • Published:
Basic Research in Cardiology Aims and scope Submit manuscript

Abstract

An increase in dispersion of myocardial refractoriness has been shown to coincide with a greater risk of inducible ventricular arrhythmias. We compared the dispersion of electrophysiologic parameters and antiarrhythmic effects of dofetilide (0.03, 0.1, 0.3 and 1 mg/kg i.v.) in postinfarcted anesthetized dogs. Animals were tested for inducibility of arrhythmias using a programmed electrical stimulation (PES) protocol, and divided into inducible (1) and non-inducible (NI) groups. In addition, myocardial vulnerability was measured using ventricular fibrillation thresholds (VFT), as well as susceptibility to sudden cardiac death (SCD). Dofetilide significantly increased ventricular effective refractory periods (ERP) and monophasic action potential durations (APD) in a dose-dependent manner. The standard deviation of ERP, which was used as an index of dispersion of refractoriness, increased from sham (control value of 5.4±sd2.5 ms), non-inducible (control value of 11.0 ±5.5 and 8.0±3.7 ms for vehicle and dofetilide groups, respectively) and inducible states (control value of 17.3±6.2 and 21.6±7.1 ms for vehicle and dofetilide groups, respectively). However, dofetilide treatment did not alter dispersion of refractoriness over the dose range studied. Dofetilide did not significantly increase inducibility in the NI group (2 out of 8[25%] compared to 0 out of 9 [0 %] in vehicle treated animals). In the I group, dofetilide (0.3 mg/kg) treated animals converted 2 out of 7 (29 %) to NI, and 5 out of 7 (71 %; significant at p<0.05) to a NI or non sustained ventricular tachycardia. There were no significant changes in VFT following the last dose of dofetilide given. Dofetilide did not significantly affect SCD survival (88 % and 29 % in the NI and I group, resectively) relauve to vehicle (66 % and 50 % in the NI and I group, respectively). Although infarct sizes were significantly greater in the I groups, there was no difference between vehicle and dofetilide animals within these groups. In conclusion, dofetilide increased ERP and APD values, but did not affect dispersion of refractoriness. Thus, changes in dispersion of refractori ness may be used as a marker for inducibility in untreated animals, but it did not predict the antiarrhythmic effects observed with dofetilide.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Allessie MA, Bonke FIM, Schopman FJG (1976) Circus movement in rabbit atrial muscle as a mechanism of tachycardia: II. The role of nonuniform recovery of excitability in the occurrence of unidirectional block, as studied with multiple electrodes. Circ Res 39: 168–177

    Google Scholar 

  2. Anderson JL, Rodier HE, Green LS (1983) Comparative effects of betaadrenergic blocking drugs on experimental fibrillation threshold. Am J Cardiol 51: 1196–1202

    Google Scholar 

  3. Antzelevitch C, Sicouri S, Litovsky SH, Lukas A, Krishnan SC, DiDiego JM, Gintant GA, Liu D-W (1991) Heterogeneity within the ventricular wall. Electrophysiology and pharmacology of epicardial, endocardial and M cells. Circ Res 69: 1427–1449

    Google Scholar 

  4. Barber MJ, Mueller TM, Henry DP, Felten SY, Zipes DP (1983) Transmural myocardial infarction in the dog produces sympathectomy in noninfarcted myocardium. Circulation 67: 787–796

    Google Scholar 

  5. Black SC, Chi L, Mu D-X, Lucchesi BR (1991) The antifibrillatory actions of UK-68-798, a Class III antiarrhythmic agent. J Pharmacol Exp Then 258: 416–423

    Google Scholar 

  6. Black SC, Lucchesi BR (1992) UK-68-798, a class III antiarrhythmic drug with antifibrillatory properties. Cardiovasc Drug Rev 10: 170–181

    Google Scholar 

  7. Butrous GS, Gough WB, Restivo M, Yang H, El-Sherif N (1992) Adrenergic effects on reentrant ventricular rhythms in subacute myocardial infarction. Circulation 86: 247–254

    Google Scholar 

  8. Carmeliet E (1992) Voltage-and timedependent block of the delayed K+ current in cardiac myocytes by dofetilide. J Pharmacol Exper Ther 262: 809–817

    Google Scholar 

  9. Corr PB, Shayman JA, Kramer JB, Kipnis RJ (1981) Increased α-adrenergic receptors in ischemic cat myocardium. J Clin Invest 67: 1232–1236

    Google Scholar 

  10. El-Sherif N, Gough WB, Restivo M (1991) Reentrant ventricular arrhythmias in the late myocardial infarction period. Mechanism by which a shortlong-short cardiac sequence facilitates the induction of reentry. Circulation 83: 268–278

    Google Scholar 

  11. Gough WB, eehra R, Restivo M, Zieler RH, El-Sherif N (1985) Reentrant ventricular arrhythmias in the late myocardial infarction period in the dog: 13. Correlation of activation and refractory maps. Circ Res 57: 432–442

    Google Scholar 

  12. Greenberg SS, Luisi A, Long JP, Williamson HE (1992) Pharmacology of sematilide, a non-quaternary class III antiarrhythmic agent. Drug Dev Res 25: 283–302

    Google Scholar 

  13. Gwilt M, Blackburn KJ, Burges RA, Higgins AJ, Milne AA, Solca AM (1992) Electropharmacology of dofetilide, a new class III agent, in anaesthetised dogs. Eur J Pharmacol 215: 137–144

    Google Scholar 

  14. Haberman RJ, Rials SJ, Stohler JL, Marinchak RA, Kowey PR (1993) Evidence for a reexcitability gap in man after treatment with type I antiarrhyth mic drugs. Am Heart J 126: 1121–1126

    Google Scholar 

  15. Han J, Moe GK (1964) Nonuniform recovery of excitability in ventricular muscle. Circ Res 14: 44–60

    Google Scholar 

  16. Kammerling JJ, Green FJ, Watanabe AM, Inoue H, Barber MJ, Henry DP, Zipes DP (1987) Denervation supersensitivity of refractoriness in noninfareted areas apical to transmural myocardial infarction. Circulation 76: 383–393

    Google Scholar 

  17. Kiehn J, Villena P, Beyer T, Brachmann J (1994) Differential effects of the new Class III agent dofetilide on potassium currents in guinea pig cardiomyocytes. J Cardiovasc Pharmacol 24: 566–572

    Google Scholar 

  18. Kowey PR, Friehling TD, Sewter J, Wu Y, Sokil A, Paul J, Nocella J (1991) Electrophysiological effects of left ventricular hypertrophy. Effect of calcium and potassium channel blockade. Circulation 83: 2067–2075

    Google Scholar 

  19. Krishnan SC, Antzelevitch C (1991) Sodium channel block produces opposite electrophysiologic effects in canine ventricular epicardium and endocardium. Circ Res 69: 277–291

    Google Scholar 

  20. Liu D-W, Gintant GA, Antzelevitch C (1993) Ionic bases for electrophysiological distinctions among epicardial, midmyocardial, and endocardial myocytes from the free wall of the canine left ventricle. Circ Res 72: 671–687

    Google Scholar 

  21. Mehra R, Zeiler RH, Gough WB, El-Sherif N (1993) Reentrant ventricular arrhythmias in the late myocardial infarction period: 9. Electrophysiologicanatomic correlation of reentrant circuits. Circulation 67: 11–24

    Google Scholar 

  22. Michelson EL, Spear JF, Moore EN (1980) Electrophysiologic and anatomic correlates of sustained ventricular tachyarrhythmias in a model of chronic myocardial infarction. Am J Cardiol 45: 583–590

    Google Scholar 

  23. Mines GR (1914) On circulating excitations in heart muscle and their possible relation to tachycardia and fibrillation. Trans R Soc Can 8: 43–52

    Google Scholar 

  24. Moore EN, Spear JF, (1975) Ventricular fibrillation threshold. Arch Intern Med 135: 446–453

    Google Scholar 

  25. Morgan JM, Cunningham D, Rowland E (1992) Dispersion of monophasic action potential duration: Demonstrable in humans after premature ventricular extrastimulation but not in steady state. J Am Coll Cardiol 19: 1244–1253

    Google Scholar 

  26. Mukherjee A, Wong TM, Buja LM, Lefkowitz RJ, Willerson JT (1979) Betaadrenergic and muscarinic cholinergic receptors in canine myocardium. Effects of ischemia. J Clin Invest 64: 1423–1428

    Google Scholar 

  27. Nelson SD, Coyne K (1992) Electrophysiologic effects of selective B1 adrenergic stimulation in the late phase of myocardial healing. Intern J Cardiol 36: 95–102

    Google Scholar 

  28. Ogawa A, Furuno I, Satoh Y, Yoh S, Saeki K, Sadanaga T, Katoh H, Nakamura Y (1991) Quantitative indices of dispersion of refractoriness for identification of propensity to re-entrant ventricular tachycardia in a canine model of myocardial infarction. Cardiovasc Res 25: 378–383

    Google Scholar 

  29. Rasmussen HS, Allen MJ, Blackburn KJ, Butrous GS, Dalrymple HW (1992) Dofetilide, a novel class III antiarrhythmic agent. J Cardiovasc Pharmacol 20: S96-S105

    Google Scholar 

  30. Rosen MR, Gelband H, Hoffman BE (1971) Effects of phentolamine on electrophysiologic properties of isolated canine Purkinje fibres. J Pharmacol Exp Ther 179: 586–593

    Google Scholar 

  31. Sanguinetti MC, Jurkiewicz NK (1990) Two components of cardiac delayed rectifier K+ current. J Gen Physiol 96: 195–215

    Google Scholar 

  32. Scaelse RJ, Burkett DE, Sadanaga KK, D'Alonzo AJ, Barbour S, Clemons AF, Darbenzio RB, Hess TA, Sedlatschek MA, Sewter JC (1993) Coronary artery occlusion/reperfusion. A canine model of myocardial infarction. A retrospective study in 211 dogs: Results and research applications. J Invest Surg 6: 380

    Google Scholar 

  33. Segwick ML, Rasmussen HS, Cobbe SM (1992) Effects of the Class III antiarrythmic drug dofetilide on ventricural monophasic action potential duration and QT interval dispersion in stable angina pectoris. Am J Cardiol 70: 1432–1437

    Google Scholar 

  34. Sheridan DJ, Culling W (1985) Electrophysiological effects of α-adrenoceptor stimulation in normal and ischemic myocardium. J Cardiovasc Phamacol 7: S55–60

    Google Scholar 

  35. Spinelli W, Parsons RW, Colatsky TJ (1992) Effects of WAY-123, 398 a new class III antiarrhythmic, on cardiac refractoriness and ventricular fibrillation threshold in anesthetized dogs: A comparison with UK-68798, E-4031, and dl-sotalol. J Cardiovasc Pharmacol 20: 913–922

    Google Scholar 

  36. Tanabe T, Takahashi K, Usui K, Kitada M, Mori H (1993) Effects of bunazosin, a selectiveα 1-blocking agent, and propranolol used alone and in combination on canine ventricular refractoripess and its dispersion during myocardial ischemia. J Cardiovasc Pharmacol 21: 600–608

    Google Scholar 

  37. Wetstein L, Mark R, Kelliher GJ, Friehling T, O'Connor KM, Kowey PR (1985) Arrhythmia inducibility and ventricular vulnerability in a chronic feline infarction model. Am Heart J 110: 955–960

    Google Scholar 

  38. Wilber DJ, Lynch JJ, Lucchesi BR (1985) Electrophysiologic effects of prazocin during acute myocardial ischemia. Eur J Pharmacol 127: 157–161

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

D'Alonzo, A.J., Sewter, J.C., Darbenzio, R.B. et al. Effects of dofetilide on electrical dispersion and arrhythmias in post-infarcted anesthetized dogs. Basic Res Cardiol 90, 424–434 (1995). https://doi.org/10.1007/BF00788505

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00788505

Key words

Navigation